Related Experiment Video
Updated: Nov 9, 2025

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Nuclear ErbB2 represses DEPTOR transcription to inhibit autophagy in breast cancer cells
Yanli Bi1,2,3, Longyuan Gong1,2,3, Pengyuan Liu3
1Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Abstract:
ErbB2, a classical receptor tyrosine kinase, is frequently overexpressed in breast cancer cells. Although the role of ErbB2 in the transmission of extracellular signals to intracellular matrix has been widely studied, the functions of nuclear ErbB2 remain largely elusive. Here, we report a novel function of nuclear ErbB2 in repressing the transcription of DEPTOR, a direct inhibitor of mTOR. Nuclear ErbB2 directly binds to the consensus binding sequence in the DEPTOR promoter to repress its transcription. The kinase activity of ErbB2 is required for its nuclear translocation and transcriptional repression of DEPTOR. Moreover, the repressed DEPTOR by nuclear ErbB2 inhibits the induction of autophagy by activating mTORC1. Thus, our study reveals a novel mechanism for autophagy regulation by functional ErbB2, which translocates to the nucleus and acts as a transcriptional regulator to suppress DEPTOR transcription, leading to activation of the PI3K/AKT/mTOR pathway to inhibit autophagy.
Insights
Nuclear ErbB2, a receptor tyrosine kinase, represses DEPTOR transcription, inhibiting autophagy. This novel nuclear function of ErbB2 activates mTORC1, impacting breast cancer cell signaling and autophagy regulation.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- ErbB2 (human epidermal growth factor receptor 2) is a receptor tyrosine kinase often overexpressed in breast cancer.
- While ErbB2's role in extracellular signaling is known, its nuclear functions are poorly understood.
- DEPTOR is a direct inhibitor of the mechanistic target of rapamycin (mTOR) pathway.
Purpose of the Study:
- To investigate the novel functions of nuclear ErbB2 in breast cancer cells.
- To elucidate the mechanism by which nuclear ErbB2 regulates DEPTOR transcription.
- To understand the impact of nuclear ErbB2 on autophagy and the PI3K/AKT/mTOR pathway.
Main Methods:
- Chromatin immunoprecipitation assays to identify nuclear ErbB2 binding sites.
- Reporter assays to assess transcriptional regulation of DEPTOR.
- Kinase activity assays and nuclear translocation studies.
- Analysis of autophagy induction and mTORC1 activity.
Main Results:
- Nuclear ErbB2 directly binds to the DEPTOR promoter, repressing its transcription.
- ErbB2 kinase activity is essential for its nuclear localization and DEPTOR repression.
- Repressed DEPTOR by nuclear ErbB2 leads to mTORC1 activation and inhibition of autophagy.
- This mechanism involves the PI3K/AKT/mTOR pathway.
Conclusions:
- Nuclear ErbB2 acts as a transcriptional repressor of DEPTOR.
- This nuclear function of ErbB2 provides a novel mechanism for autophagy regulation.
- Targeting nuclear ErbB2 activity could offer new therapeutic strategies for breast cancer.
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Negative Regulator Molecules
Regulation of Nuclear Protein Sorting

